Purpose: Currently, the American Colleges of Medical Genetics and Obstetrics and Gynecology recommend screening in the prenatal setting only for individuals with specific family history indicators.
A diagnostic test for fragile X syndrome (FXS) has been cleared by the Food and Drug Administration. A diagnostic test for fragile X syndrome (FXS) has been cleared by the Food and Drug Administration ...